Both refer to the same triple agonist (GLP-1, GIP, and glucagon) research peptide, so Reta and Retatrutide are interchangeable
The compound is the same synthetic triple receptor agonist at GIPR, GLP-1R and GCGR across every vial size, molecular formula CHNO, molecular weight 4731.3 g/mol, CAS 2381089-83-2
These patches lack scientific evidence and have provided potential results only in certain trial-based studies, which cannot be considered safe
How effective is Ozempic for weight loss compared to other GLP-1 treatments
Partner tip Managing your weight can help lower your risk of heart disease, regulate your blood sugar, and ease menopause symptoms, like hot flashes and night sweats
These patches claim to use a slow-release transdermal technology that delivers the drug into your bloodstream through the skin, gradually